Skip to main content
颖泰生物 logo

颖泰生物 — Investor Relations & Filings

Ticker · 920819 Beijing Stock Exchange Manufacturing
Open in API
Filings indexed 419 across all filing types
Latest filing 2025-02-20 Earnings Release
Country CN China
Listing Beijing Stock Exchange 920819

About 颖泰生物

https://www.nutrichem.cn/

Nutrichem Company Limited focuses on the research, development, production, and distribution of agrochemical active ingredients and formulations. The product portfolio includes a diverse array of herbicides, fungicides, and insecticides tailored for global agricultural applications. The company provides comprehensive contract development and manufacturing organization (CDMO) services, supporting international partners through the entire product lifecycle from synthesis to commercial-scale production. With a strong emphasis on research and development, Nutrichem utilizes advanced chemical synthesis technologies and process optimization to ensure high-quality output and operational efficiency. Its integrated supply chain and large-scale manufacturing infrastructure enable the delivery of customized crop protection solutions to meet the evolving needs of the global agricultural sector.

Recent filings

Filing Released Lang Actions
2024年年度业绩快报公告
Earnings Release Classification · 95% confidence The document is titled as a "2024 年年度业绩快报公告" which translates to "2024 Annual Performance Express Announcement". It contains preliminary financial data and key financial indicators for the year 2024, including revenue, profit, net profit attributable to shareholders, earnings per share, and asset information. The document explicitly states that the data are preliminary and unaudited, and that the final audited data will be disclosed in the 2024 Annual Report. The document is relatively short (1959 characters) and serves as an initial announcement of annual financial results rather than a full detailed annual report. This matches the definition of an Earnings Release (ER), which is the initial announcement of quarterly or periodical financial results with key highlights only. It is not the full Annual Report (10-K), nor an announcement of the report publication (RPA), nor a certification or regulatory filing (RNS). Therefore, the correct classification is Earnings Release (ER). FY 2024
2025-02-20 Chinese
关于募集资金专户完成销户的公告
Capital/Financing Update Classification · 95% confidence The document is an announcement regarding the completion of the closure of a special account for raised funds. It details the background of the fundraising, the management of the funds, the use of the funds, and the formal closure of the fundraising special account. It includes references to regulatory approvals, shareholder meetings, and agreements related to the fundraising account. The document is relatively short (2178 characters) and serves as a formal notification about the status of the fundraising account rather than a detailed financial report or audit. It does not contain comprehensive financial statements or detailed financial analysis. Therefore, it fits best into the category of Capital/Financing Update (CAP), which covers updates on company fundraising and capital structure changes.
2025-02-17 Chinese
2024年年度业绩预告公告
Earnings Release Classification · 95% confidence The document is a 2024 annual performance forecast announcement by Beijing Yingtai Jiahe Biotechnology Co., Ltd. It provides preliminary unaudited financial data for the full year 2024, including expected net profit range and reasons for significant changes compared to the prior year. It explicitly states that the data are preliminary and unaudited, and the final audited figures will be disclosed in the official 2024 annual report. The document length is short (932 characters) and it serves as a performance forecast rather than a full annual report. According to the rules, such preliminary earnings forecasts or performance outlooks are classified as Earnings Release (ER) since they provide initial key financial results highlights for the fiscal year but are not the full audited report (10-K). FY 2024
2025-01-16 Chinese
投资者关系活动记录表
Investor Presentation Classification · 90% confidence The document is titled as an "投资者关系活动记录表" which translates to "Investor Relations Activity Record." It details a specific investor relations event held on January 15, 2025, including participants, questions asked, and company responses about policies, sales, projects, and industry outlook. The content is a record of a specific investor relations activity rather than a financial report, earnings release, or regulatory filing. It is not a full transcript of a conference call but a summary of an investor meeting or research session. The document length is 2203 characters, which is relatively short and focused on investor relations activities. Therefore, the most appropriate classification is Investor Presentation (IP), as it is a detailed presentation for investors focusing on company strategy, market position, and financial outlook, even though it is in a record format rather than a slide deck. It is not an announcement of a report, nor a regulatory filing, nor a management report. Hence, the classification is IP with high confidence.
2025-01-15 Chinese
关于控股子公司获得农业转基因生物安全证书的公告
Regulatory Filings Classification · 95% confidence The document is an announcement from Beijing Yingtai Jiahe Biotechnology Co., Ltd. regarding its controlling subsidiary obtaining an agricultural genetically modified organism (GMO) biosafety certificate. It details the approval of a specific GMO corn product and its implications for the company. The document is short (1238 characters) and focuses on regulatory approval and business impact rather than financial data or detailed reporting. It does not contain financial statements, earnings data, or management discussion of financial results. It is not a report but an announcement of a regulatory milestone. Therefore, it fits best under Regulatory Filings (RNS), which covers general regulatory announcements and compliance documents that do not fit other categories.
2024-12-30 Chinese
2024年第一次临时股东大会决议公告
Declaration of Voting Results & Voting Rights Announcements Classification · 100% confidence The document is a detailed announcement of the resolutions passed at the 2024 first extraordinary general meeting of shareholders of Beijing Yingtai Jiahe Biotechnology Co., Ltd. It includes information about the meeting's convening, attendance, voting results on various proposals, and changes in board members and senior management. The document contains specific voting results and details about board member appointments and resignations, which are typical contents of a Declaration of Voting Results & Voting Rights Announcements filing. The document length is 4383 characters, which is sufficient to contain substantive voting results rather than just an announcement of a report. Therefore, the document fits best under the category of Declaration of Voting Results & Voting Rights Announcements (DVA).
2024-12-26 Chinese

Browse filings by year

6 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.